AakashDesaiMD

Oncology • Birmingham, AL

Hematologic Oncology

Assistant Professor, University of Alabama at Birmingham

Join to view full profile

Dr. Desai is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Desai's full profile

Already have an account?

Office
2000 Sixth Ave S
Birmingham, AL 35233

Education & Training

B. J. Medical College AhmedabadClass of 2015

Certifications & Licensure

AL State Medical License 2023 - 2025
MN State Medical License 2020 - 2024
CT State Medical License 2017 - 2020
MD State Medical License 2011 - 2018
VA State Medical License 2011 - 2018
DC State Medical License 2011 - 2016
IL State Medical License 2011 - 2014
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors Start of enrollment: 2022 Apr 14
Recruiting
Phase 1, Phase 2
Roles: Principal Investigator
DISCERN: Dual Versus Single ICB in PDL-1 Negative NSCLC Start of enrollment: 2024 Oct 31
Not yet recruiting
Phase 2
Roles: Principal Investigator, Contact

Publications & Presentations

PubMed

Guide to Understanding and Supporting International Medical Graduates in Hematology/Oncology by the ASCO International Medical Graduates Community of Practice.
Nazli Dizman, Ziad Bakouny, Tarek Haykal, Ivy Riano, Aakash Desai
JCO Oncology Practice. 2024-10-07
Double agents in immunotherapy: Unmasking the role of antibody drug conjugates in immune checkpoint targeting.
Sruthi Ranganathan, Aswanth Reddy, Alessandro Russo, Umberto Malepelle, Aakash Desai
Critical Reviews in Oncology/hematology. 2024-10-01
Predictive value and molecular correlates of MYC immunohistochemistry and copy number gain in non-small cell lung carcinomas treated with immunotherapy.
Julia Naso, Aakash Desai, Caleb J Smith, Yash P Ashara, Stephen Yip
Lung Cancer. 2024-09-01

Press Mentions

Thoracic Cancer Approvals Differ at FDA, EMAApril 7th, 2023
Face-Covering Use up, More People Are Taking COVID-19 Threats Seriously, Study FindsSeptember 23rd, 2020
Visas, Barriers, and Dreams: IMGs in Oncology Face Unique ChallengesJune 13th, 2023